论文部分内容阅读
奈西立肽联合使用静脉内利尿剂和正性肌力药物的安全性和有效性尚待研究。而探讨奈西立肽治疗前的药物治疗类型是否会对患者结局有影响的资料亦匮乏。回顾性分析167例接受奈西立肽治疗、左室射血分数降低(34%±17%)的心力衰竭患者的资料。基线时的
The safety and efficacy of nesiritide in combination with intravenous diuretics and inotropic drugs remains to be studied. However, there is a lack of information on whether the type of drug treatment before nesiritide treatment affects patient outcomes. Data from 167 patients with heart failure who received nesiritide and who had a reduced left ventricular ejection fraction (34% ± 17%) were retrospectively analyzed. At baseline